Literature DB >> 8201221

Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease.

A von Herbay1, H de Groot, U Hegi, W Stremmel, G Strohmeyer, H Sies.   

Abstract

The RRR-alpha-tocopherol (vitamin E) content in plasma from 46 patients with liver diseases and 23 healthy controls was determined by high performance liquid chromatography and electrochemical detection. Patients were divided into three groups: alcoholic liver diseases (n = 17; group A), hemochromatosis (n = 17; group B) and Wilson's disease (n = 12; group C). Lipid-standardized alpha-tocopherol levels were determined to neutralize differences due to hyperlipemia. The ratio of serum vitamin E to serum lipids (cholesterol, triglycerides, phospholipids) was highest in healthy controls and in patients in group A with cirrhosis and normal transaminases and bilirubin. Patients in group A with acute or chronic ethanol intoxication and high bilirubin levels had a 37% lower lipid-standardized vitamin E level than controls. Patients in group B with hemochromatosis, showing high serum iron (> 180 micrograms/dl), a low free iron binding capacity (< 8 mumol/l) and high ferritin-levels (< 450 micrograms/l), had a 34% lower vitamin E/lipid ratio than healthy controls. No significant lowering of the vitamin E/lipid ratio was observed in the other patients in group B. A significant decrease (37%) in the vitamin E/lipid ratio was only detectable in patients with Wilson's disease (group C) showing high free serum copper (> 10 micrograms/dl). The data support a role for free radicals in the pathogenesis of active liver diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8201221

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

1.  Wilson's disease: A review of what we have learned.

Authors:  Kryssia Isabel Rodriguez-Castro; Francisco Javier Hevia-Urrutia; Giacomo Carlo Sturniolo
Journal:  World J Hepatol       Date:  2015-12-18

2.  Bone demineralisation in a large cohort of Wilson disease patients.

Authors:  Karl Heinz Weiss; Mart Van de Moortele; Daniel Nils Gotthardt; Jan Pfeiffenberger; Jessica Seessle; Elena Ullrich; Evelien Gielen; Herman Borghs; Els Adriaens; Wolfgang Stremmel; Wouter Meersseman; Steven Boonen; David Cassiman
Journal:  J Inherit Metab Dis       Date:  2015-02-07       Impact factor: 4.982

Review 3.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 4.  Iron toxicity and chelation therapy.

Authors:  Robert S Britton; Katherine L Leicester; Bruce R Bacon
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

Review 5.  A review and current perspective on Wilson disease.

Authors:  Mallikarjun Patil; Keyur A Sheth; Adarsh C Krishnamurthy; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2013-07-06

6.  Disordered vascular compliance in haemochromatosis.

Authors:  W J Cash; S O'Neill; M E O'Donnell; D R McCance; I S Young; J McEneny; I S Cadden; Neil I McDougall; M E Callender
Journal:  Ir J Med Sci       Date:  2013-09-03       Impact factor: 1.568

7.  Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms.

Authors:  Radan Bruha; Libor Vitek; Zdenek Marecek; Lenka Pospisilova; Sona Nevsimalova; Pavel Martasek; Jaromir Petrtyl; Petr Urbanek; Alena Jiraskova; Ivana Malikova; Martin Haluzik; Peter Ferenci
Journal:  J Inherit Metab Dis       Date:  2011-12-03       Impact factor: 4.982

Review 8.  Is there any use for nontraditional or alternative therapies in patients with chronic liver disease?

Authors:  N M Bass
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

Review 9.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

10.  Redox pioneer: professor Helmut Sies.

Authors:  Dean P Jones; Rafael Radi
Journal:  Antioxid Redox Signal       Date:  2014-10-09       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.